A composition for food and a fat absorption inhibitor, each including a seaweed polyphenol and a tea extract.

The present invention relates to an antioxidant composition and, more specifically, to an antioxidant composition including a Sargassum serratifolium extract or a fraction thereof as an active ingredient, in which the antioxidant composition is a useful material (substance) that can be added to medicines, cosmetics, foods, animal feeds, and the like. The present invention also relates to a pharmaceutical composition for preventing or treating eye diseases, a food composition for alleviating eye diseases, and a health functional food, each of which includes a Sargassum serratifolium extract or a compound separated therefrom as an active ingredient.

The present invention relates to an antioxidant composition and, more specifically, to an antioxidant composition including a Sargassum serratifolium extract or a fraction thereof as an active ingredient, in which the antioxidant composition is a useful material (substance) that can be added to medicines, cosmetics, foods, animal feeds, and the like. The present invention also relates to a pharmaceutical composition for preventing or treating eye diseases, a food composition for alleviating eye diseases, and a health functional food, each of which includes a Sargassum serratifolium extract or a compound separated therefrom as an active ingredient.

The present invention provides non-propagating transgenic microalgae expressing at least one heterologous RNAi molecule. The RNAi-expressing non-propagating transgenic microalgae are used for oral delivery of the RNAi molecule to a target organism in its intact and functional form. The heterologous RNAi molecule, present within the microalgae, is characterized by being biologically active, exerting at least one specific effect on the organism consuming the microalgae or on a pathogen of said organism. In particular, the non-propagating transgenic microalgae are used as agents for biological control of animal and plant pests.

The present invention provides non-propagating transgenic microalgae expressing at least one heterologous RNAi molecule. The RNAi-expressing non-propagating transgenic microalgae are used for oral delivery of the RNAi molecule to a target organism in its intact and functional form. The heterologous RNAi molecule, present within the microalgae, is characterized by being biologically active, exerting at least one specific effect on the organism consuming the microalgae or on a pathogen of said organism. In particular, the non-propagating transgenic microalgae are used as agents for biological control of animal and plant pests.

The present invention relates to a process for preparing an additive as a food supplement based on algae for birds and animals. It also describes the food additive obtained, formulated with seaweed extract, whey, malto-dextrin, proteins, amino acids, minerals, fiber, fat, hormones, and has a final powder form. In addition, the use of the food additive to increase the weight gain in animals, the weight gain in eggs of birds, and for the production of meat in birds and animals is described.

The present invention relates to a process for preparing an additive as a food supplement based on algae for birds and animals. It also describes the food additive obtained, formulated with seaweed extract, whey, malto-dextrin, proteins, amino acids, minerals, fiber, fat, hormones, and has a final powder form. In addition, the use of the food additive to increase the weight gain in animals, the weight gain in eggs of birds, and for the production of meat in birds and animals is described.

The disclosure relates to methods of treating obesity, abdominal obesity, dyslipidemia, pre-diabetes, or diabetes, or any related disorders thereto; and preventing or attenuating weight gain, including the regain of weight after weight loss, or alleviating or slowing the onset of weight related symptoms and/or disorders. Furthermore, the disclosure teaches methods of administering compositions comprising one or more aquatic plants to shift/optimize the gut microbiome of a patient in need. Additionally, the disclosure provides methods of enhancing the probability of maintaining weight loss and its associated health benefits by sampling a patient's gut microbiome during a period of optimal weight, generally from weight loss, and administering autologous or allogenic microbiota to the patient or to a second patient in order to maintain the weight loss and/or to further prevent or attenuate weight regain.

The disclosure relates to methods of treating obesity, abdominal obesity, dyslipidemia, pre-diabetes, or diabetes, or any related disorders thereto; and preventing or attenuating weight gain, including the regain of weight after weight loss, or alleviating or slowing the onset of weight related symptoms and/or disorders. Furthermore, the disclosure teaches methods of administering compositions comprising one or more aquatic plants to shift/optimize the gut microbiome of a patient in need. Additionally, the disclosure provides methods of enhancing the probability of maintaining weight loss and its associated health benefits by sampling a patient's gut microbiome during a period of optimal weight, generally from weight loss, and administering autologous or allogenic microbiota to the patient or to a second patient in order to maintain the weight loss and/or to further prevent or attenuate weight regain.

An ingestible compositions includes a first polymer layer, an adhesive layer associated with the first polymer layer, where the adhesive layer includes an adhesive material and is configured to releasably adhere to the first polymer layer, an alginate layer adhered to the adhesive layer, and a second polymer layer associated with the alginate layer and configured to releasably adhere to the alginate layer. Aspects further include methods of making and using the compositions.